{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:02:23Z","timestamp":1787068943752,"version":"build-2736575974"},"reference-count":17,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100005258","name":"National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention","doi-asserted-by":"crossref","award":["PS21-2103"],"award-info":[{"award-number":["PS21-2103"]}],"id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Telemedicine and e-Health"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Achieving hepatitis C virus (HCV) elimination goals requires a test and treat approach in high-prevalence settings. Clients admitted to inpatient substance use treatment programs (ISUTPs) have a high burden of HCV infection, yet routine screening and treatment are not standard practice in these settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A telehealth model of HCV treatment was implemented at four ISUTPs (spokes) in partnership with a primary care program (hub) with the goal of starting clients on treatment at the ISUTP. Continuous process evaluation identified implementation barriers, which were addressed through the introduction of a community health worker (CHW) model of telehealth facilitation, cocredentialing of the CHW at spoke sites, and partnership with the onsite pharmacy at the hub.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Over the course of 3 years, 164 clients completed an initial telehealth visit at the ISUTP. Among those evaluated, 80% reported recent intravenous drug use, and 51% were unhoused. One hundred and seven (65%) initiated HCV treatment, and 44 (41%) had sustained virologic response (SVR) at 12 weeks posttreatment. As the model of care was refined, more patients started on treatment while at the ISUTP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These data demonstrate the feasibility of a test and treat approach for HCV in ISUTPs through a facilitated telehealth model. While documented SVR rates were low compared to other studies, this strategy nonetheless has the potential to reduce HCV transmission at a population level. Future efforts should focus on expanding this model and minimizing loss to follow-up postdischarge from the ISUTP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15305627251406807","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T04:16:48Z","timestamp":1766722608000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating Hepatitis C Virus Services for People Who Use Drugs into Inpatient Substance Use Disorder Treatment Programs Via Telehealth"],"prefix":"10.1177","volume":"32","author":[{"given":"Farah","family":"Riazi","sequence":"first","affiliation":[{"name":"Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrinne","family":"Green","sequence":"additional","affiliation":[{"name":"Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamar","family":"Smalls","sequence":"additional","affiliation":[{"name":"Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Hunter","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Diaz Munoz","sequence":"additional","affiliation":[{"name":"Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Fuseau","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Giardina","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Herrera","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Idlett","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umaima","family":"Khatun","sequence":"additional","affiliation":[{"name":"Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kutscher","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000927"},{"key":"e_1_3_3_3_2","unstructured":"Plan to Eliminate Viral Hepatitis as a Major Public Health Threat in New York City by 2030. New York City Department of Health and Mental Hygiene; 2021. Available from: http:\/\/viral-hepatitis-elimination-plan.pdf"},{"key":"e_1_3_3_4_2","unstructured":"Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021-2025). Washington DC: U.S. Department of Health abd Human Services. 2020. Available from: http:\/\/ViralHepatitisFederalImplementationPlan|HHS.gov"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.05.006"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2011.12.008"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/00333549211049263"},{"key":"e_1_3_3_8_2","unstructured":"Prevention USCfDCa. 2024 National Progress Report: Hepatitis C Virus \u2013 Reduce Rate Among PWID (Viral Hepatitis p. 11). U.S. Centers for Disease Control and Prevention; 2024. Available from: 2024NationalViralHepatitisProgressReport|ViralHepatitis|CDC"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy899"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.2196\/53049"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2452"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001492"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13854"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.11.008"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2021.0130"},{"key":"e_1_3_3_16_2","unstructured":"Hepatitis A B and C in New York City: 2023 Annual Report. Long Island City NY: New York City Department of Health and Mental Hygiene; 2023. Working Toward a Hep Free N Y C - 2023 Hepatitis A B and C in N Y C Report."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.7.664"},{"key":"e_1_3_3_18_2","unstructured":"HCV Guidance: Recommendations for Testing Managing and Treating Hepatitis C American Association for the Study of Liver Diseases and the Infectious Diseases Society of America 2025. Available from: http:\/\/HepCTestInitialVisit_NEWFigure1_Version1"}],"container-title":["Telemedicine and e-Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15305627251406807","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15305627251406807","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15305627251406807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:14:26Z","timestamp":1787066066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15305627251406807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"alternative-id":["10.1177\/15305627251406807"],"URL":"https:\/\/doi.org\/10.1177\/15305627251406807","relation":{},"ISSN":["1530-5627","1556-3669"],"issn-type":[{"value":"1530-5627","type":"print"},{"value":"1556-3669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}